52,325 Shares in Agilent Technologies, Inc. $A Acquired by OP Asset Management Ltd

OP Asset Management Ltd acquired a new stake in Agilent Technologies, Inc. (NYSE:A) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 52,325 shares of the medical research company’s stock, valued at approximately $5,964,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the fourth quarter worth $26,000. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies during the 4th quarter valued at $26,000. Board of the Pension Protection Fund acquired a new stake in shares of Agilent Technologies during the 4th quarter valued at $27,000. Navalign LLC bought a new stake in Agilent Technologies during the 4th quarter worth $27,000. Finally, MV Capital Management Inc. bought a new stake in Agilent Technologies during the 4th quarter worth $28,000.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent completed its acquisition of Biocare Medical, adding immunohistochemistry, in situ hybridization and fluorescence in situ hybridization solutions to its portfolio, which could support longer-term revenue growth and cross-selling opportunities. Article Title
• Positive Sentiment: Barclays raised its price target on Agilent and reiterated an overweight view, signaling Wall Street sees additional upside from current levels. Article Title
• Neutral Sentiment: Piper Sandler initiated coverage with a neutral rating and a $150 price target, which supports valuation but is not an outright bullish call. Article Title
• Neutral Sentiment: Agilent also announced that Shanghai ICRD adopted its software, a modest business win that reinforces demand for its lab and workflow tools. Article Title

Agilent Technologies Stock Up 3.1%

Shares of A opened at $135.73 on Friday. The stock’s 50-day moving average price is $122.53 and its two-hundred day moving average price is $126.25. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a market capitalization of $38.33 billion, a PE ratio of 27.25, a PEG ratio of 2.34 and a beta of 1.26. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. The business’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analysts Set New Price Targets

A has been the subject of several research reports. Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Morgan Stanley lowered their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. HSBC dropped their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $161.27.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.